SIGA Technologies, Inc.

SIGA Technologies, Inc.

SIGANYSE / NASDAQHealthcareSmall cap

$2.40-$0.25 (-9.4%)

Last close · Data as of Nov 20, 2026

Market cap
$317.7M
P/E
13.6x
EV / EBITDA
6.7x
Revenue
$94.6M
Net margin
24.6%
ROCE
11.8%

-58.4% over the last year

SIGA Technologies, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-23.8%
3M
-19.2%
6M
-46.5%
1Y
-58.4%
5Y
-74.1%

52-week range

Day change -$0.25 (-9.4%) from $2.65 to $2.40 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in SIGA, bought on each weekday since 2021.

News & filings

What SIGA Technologies filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernReturn on equity fell from 27.4% to 11.7% between fiscal 2024 and fiscal 2025.

Strengths (1)

  • Free cash flow was 45.6% of revenue in fiscal 2025.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Sector
Healthcare
Shares outstanding
70.5M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$317.7M
P/E
13.6x
P/B
1.6x
EV / EBITDA
6.7x
EV / Sales
1.7x
P/S
3.4x
52-week high
$6.95
52-week low
$2.40

Profitability

Operating margin
25.1%
Net margin
24.6%
EBITDA margin
25.7%
ROE
11.7%
ROCE
11.8%
ROIC
40.9%
ROA
10.6%
Asset turnover
0.43

Growth

Revenue
$94.6M
Revenue growth, 1Y
-31.8%
Revenue CAGR, 3Y
-5.1%
Net profit growth, 1Y
-60.7%
Free cash flow
$43.1M

Solvency

Current ratio
11.83
Debt / Equity
0.00
Debt / Assets
0.00
CFO / Net profit
1.87
Cash / Market cap
48.8%

Where the revenue went

Of every $100 of FY2025 revenue, $25 was left as net income.

SIGA Technologies, Inc. income statement flow, FY2025
SIGA Technologies, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$29.7M
RevenueGross profit$64.9M
Gross profitOperating expenses$41.2M
Gross profitOperating income$23.7M
Operating incomePretax income$23.7M
Interest and other incomePretax income$6.7M
Pretax incomeTax and other$7.1M
Pretax incomeNet income$23.3M

Revenue and net profit

Revenue fell 31.8% in FY2025; net profit is the dashed line.

SIGA Technologies, Inc. revenue and net profit by fiscal year
SIGA Technologies, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$110.8M$33.9M
FY2023$139.9M$68.1M
FY2024$138.7M$59.2M
FY2025$94.6M$23.3M

Cash flows

FY2025: $43.5M from operations, $43.1M free after investment (dashed).

SIGA Technologies, Inc. operating and free cash flow by fiscal year
SIGA Technologies, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$41.6M$41.6M
FY2023$94.8M$94.8M
FY2024$48.8M$48.7M
FY2025$43.5M$43.1M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$94.6M-31.8%1Y
EBITDA
$24.3M-65.6%1Y
Net profit
$23.3M-60.7%1Y
Cash from operations
$43.5M-10.8%1Y
Free cash flow
$43.1M-11.5%1Y
Revenue CAGR, 3Y
-5.1%
Net profit CAGR, 3Y
-11.8%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$94.6M$24.3M$23.3M$43.1M11.7%-31.8%-60.7%

Monthly returns

Month-by-month returns of SIGA across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$219.5M
Liabilities$20.6M
Equity$198.8M
Paid-in capital$241.9M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; SIGA highlighted.

P/E against peers

SIGA trades at 13.6x earnings against a peer median of -1.4x.

  1. SIGA Technologies, Inc. (this company)13.6x

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): Rocket Pharmaceuticals, Inc., DiaMedica Therapeutics Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
SIGA Technologies, Inc.SIGAthis company$317.7M13.6x1.6x11.7%6.7x
Abeona Therapeutics Inc.ABEO$331.7M4.7x2.1x44.7%3.5x
Humacyte, Inc.HUMA$330.8M-8.1x106.4x-1313.4%-15.5x
Organogenesis Holdings Inc.ORGO$319.1M8.6x1.1x12.3%3.7x
Rocket Pharmaceuticals, Inc.RCKT$318.8M-1.4x1.2x-80.5%-1.3x
Fennec Pharmaceuticals Inc.FENC$318.2M-32.7x9.0x-27.5%-37.8x
DiaMedica Therapeutics Inc.DMAC$314.7M—5.6x-58.4%—
Electromed, Inc.ELMD$304.0M40.3x7.0x17.4%26.7x
Carlsmed, Inc.CARL$302.8M-10.2x3.1x-30.0%-8.4x
Peer median—-1.4x4.3x-28.7%-1.3x

Year-to-date ROI

SIGA since 1 January, against earlier years.

Historical volatility

SIGA's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

SIGA Technologies, Inc. operating margin by fiscal year
SIGA Technologies, Inc. operating margin by fiscal year
DateOperating margin
FY202238.5%
FY202359.8%
FY202450.4%
FY202525.1%
LineFY2025
Cost of revenueCost Of Revenue$29.7M
Gross profitGross Profit$64.9M
Operating expensesOperating Expense$41.2M
Research and developmentResearch And Development$20.0M
Selling, general and administrativeSelling General And Administration$21.2M
Other operating expensesOther Operating Expenses—
Total expensesTotal Expenses$70.9M
Pretax incomePretax Income$30.4M

Learn while you research

Academy chapters picked for SIGA Technologies, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →